8-KItem 5.02 · Officer/Director Change
BIOGEN INC. (BIIB)

Biogen ($BIIB) announced Chief Legal Officer Susan H.

Filed with the SEC on · Summarized by InvestorsBot

Biogen ($BIIB) announced Chief Legal Officer Susan H. Alexander will depart effective end of May 2026; 8‑K filed Mar 11, 2026. ⚖️📄 #Biogen #SEC

The company has initiated a search to identify the next Chief Legal Officer; investors should watch for interim coverage and successor disclosures. $BIIB 🔎 #Biogen #CorporateGovernance

The 8‑K does not disclose a reason for Alexander’s departure or any compensatory arrangements — expect updates in future filings/press releases. $BIIB 📝 #Biogen #Leadership

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from BIOGEN INC.

Biogen ($BIIB) Board elected Dr.

8-K · February 11, 2026

Feb 11, 2026 — Biogen Board Chair Caroline Dorsa announced she will not stand for re‑election at the 2026…

8-K · February 11, 2026

Biogen ($BIIB) filed a Form 8‑K on Feb 6, 2026 furnishing a press release dated Feb 6, 2026 (Exhibit 99.1)…

8-K · February 6, 2026

Biogen ($BIIB) on Feb 6, 2026 issued a press release announcing results of operations & financial…

8-K · February 6, 2026

Biogen expects a ~$222M pre-tax acquired IPR&D/upfront & milestone charge in Q4 2025, cutting GAAP and…

8-K · January 14, 2026